GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (OTCPK:CPHRF) » Definitions » Pre-Tax Income

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Pre-Tax Income : $12.68 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Cipher Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cipher Pharmaceuticals's pretax income for the three months ended in Dec. 2023 was $3.68 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $12.68 Mil. Cipher Pharmaceuticals's pretax margin was 74.82%.

During the past 13 years, Cipher Pharmaceuticals's highest Pretax Margin was 62.94%. The lowest was -3.33%. And the median was 32.67%.


Cipher Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for Cipher Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Pre-Tax Income Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.71 6.54 11.06 11.48 12.68

Cipher Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.93 2.71 3.17 3.12 3.68

Competitive Comparison of Cipher Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Cipher Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipher Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipher Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cipher Pharmaceuticals's Pre-Tax Income falls into.



Cipher Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cipher Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=10.033+0.778+0+1.87+-1.7763568394003E-15
=12.68

Cipher Pharmaceuticals's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=2.369+0.757+0+0.555+-4.4408920985006E-16
=3.68

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipher Pharmaceuticals  (OTCPK:CPHRF) Pre-Tax Income Explanation

Cipher Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=3.681/4.92
=74.82%

During the past 13 years, Cipher Pharmaceuticals's highest Pretax Margin was 62.94%. The lowest was -3.33%. And the median was 32.67%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipher Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (Cipher Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Headlines